Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy.
Reinders ME, Roemeling-van Rhijn M, Khairoun M, Lievers E, de Vries DK, Schaapherder AF, Wong SW, Zwaginga JJ, Duijs JM, van Zonneveld AJ, Hoogduijn MJ, Fibbe WE, de Fijter JW, van Kooten C, Rabelink TJ, Roelofs H.
Reinders ME, et al. Among authors: rabelink tj.
Cytotherapy. 2013 Jun;15(6):663-72. doi: 10.1016/j.jcyt.2013.01.010. Epub 2013 Feb 16.
Cytotherapy. 2013.
PMID: 23419679